These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8876880)

  • 1. Correction: chemical structures of serotonin and serotonin-receptor antagonists.
    Holder EP
    Ann Pharmacother; 1996 Sep; 30(9):1043. PubMed ID: 8876880
    [No Abstract]   [Full Text] [Related]  

  • 2. Ondansetron hydrochloride: a competitive serotonin 5-HT3 receptor blocker.
    Mohan KC; Ravikumar K
    Acta Crystallogr C; 1995 Dec; 51 ( Pt 12)():2627-9. PubMed ID: 8588861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoloration of parenteral ondansetron.
    H Tsui BC; Cave D
    Anesth Analg; 2003 Apr; 96(4):1239. PubMed ID: 12651705
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of ondansetron hydrochloride in a total parenteral nutrient admixture.
    Kirkham JC; Rutherford ET; Cunningham GN; Daneshmand KA; Falls AL
    Am J Health Syst Pharm; 1995 Jul; 52(14):1557-8. PubMed ID: 7552902
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug design.
    Blaney FE; Edge C; Phippen RW
    J Mol Graph; 1995 Jun; 13(3):165-74, 194-7. PubMed ID: 7577844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of granisetron hydrochloride with selected alkaline drugs.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Jan; 52(2):208. PubMed ID: 12879553
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and characterization of photoaffinity probes that target the 5-HT3 receptor.
    Jack T; Ruepp MD; Thompson AJ; Mühlemann O; Lochner M
    Chimia (Aarau); 2014; 68(4):239-42. PubMed ID: 24983606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
    Castejon AM; Paez X; Hernandez L; Cubeddu LX
    J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ondansetron and dexamethasone infusion upon refrigeration.
    Rolin C; Hecq JD; Vanbeckbergen DF; Jamart J; Galanti LM
    Ann Pharmacother; 2011 Jan; 45(1):130-1. PubMed ID: 21156815
    [No Abstract]   [Full Text] [Related]  

  • 11. Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
    Behnam-Motlagh P; Sandström PE; Henriksson R; Grankvist K
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):449-55. PubMed ID: 12200602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
    Martin C; Roman V; Agay D; Fatôme M
    Radiat Res; 1998 Jun; 149(6):631-6. PubMed ID: 9611102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
    Tuladhar BR; Kaisar M; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1174-8. PubMed ID: 9401783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology.
    Swain K; Pattnaik S; Sahu SC; Patnaik KK; Mallick S
    J Drug Target; 2010 Feb; 18(2):106-14. PubMed ID: 19712026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials.
    Vrabel M
    Clin J Oncol Nurs; 2007 Dec; 11(6):809-13. PubMed ID: 18063539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis.
    Tang DH; Malone DC
    Clin Ther; 2012 Feb; 34(2):282-94. PubMed ID: 22296947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
    Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.